Diagnosis, particularly of cancer and sepsis, by determining abnormal contents of apolipoprotein C-I in serum or plasma, also therapeutic use of apolipoprotein C-I

摘要

Diagnosis, early recognition, risk assessment and monitoring progression of diseases comprising determining, in a human serum or plasma sample, the content of apolipoprotein C-I (A) and/or its derivatives, is new. Disease is deduced if the measured value is significantly different from values in a healthy subject. An independent claim is also included for use of (A) to prepare an injectable composition for treatment of cancer and sepsis. ACTIVITY : Antibacterial; Immunosuppressive; Cytostatic. No biological data given. MECHANISM OF ACTION : None given.